CSIMarket
 


Comera Life Sciences Holdings Inc   (CMRA)
Other Ticker:  
 
 

CMRA's Revenue Growth by Quarter and Year

Comera Life Sciences Holdings Inc 's Revenue results by quarter and year




CMRA Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 0.25 0.00 0.00 0.00
III Quarter September 0.23 0.00 0.00 0.00
II Quarter June 0.15 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.63 0.00 0.00 0.00



CMRA Revenue forth quarter 2022 Y/Y Growth Comment
Comera Life Sciences Holdings Inc in the forth quarter 2022 achieved Revenue of $ 0.25 millions compare to recorded in same quarter a year ago.

According to the results reported in the forth quarter 2022, Comera Life Sciences Holdings Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Comera Life Sciences Holdings Inc ' s Revenue no change of % ranks overall at the positon no. in the forth quarter 2022.




CMRA Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Comera Life Sciences Holdings Inc 's forth quarter 2022 Revenue $ 0.25 millions CMRA's Income Statement
Comera Life Sciences Holdings Inc 's forth quarter 2021 Revenue $ 0.00 millions Quarterly CMRA's Income Statement
New: More CMRA's historic Revenue Growth >>


CMRA Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December 9.33 % - - -
III Quarter September 53.33 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue forth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue forth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Comera Life Sciences Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
60.11 % 33.57 % 7.04 %
(Sep 30 2022)  


CMRA's IV. Quarter Q/Q Revenue Comment
Comera Life Sciences Holdings Inc achieved in the IV. Quarter 2022 below company average Revenue increase of 9.33% quarter on quarter, to $ 0.25 millions.

IV. Quarter 2022 CMRA's performance appear to be paradoxical, albeit lower than the regular, yet it presents a quite improvement compare to the % in the IV. Quarter 2021.

Within Major Pharmaceutical Preparations industry 78 other companies have achieved higher Revenue quarter on quarter growth. While Comera Life Sciences Holdings Inc 's Revenue growth quarter on quarter, overall rank is 765.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #79
Healthcare Sector #176
Overall #765
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #79
Healthcare Sector #176
Overall #765
Revenue Q/Q Growth Statistics
High Average Low
60.11 % 33.57 % 7.04 %
(Sep 30 2022)  


CMRA's IV. Quarter Q/Q Revenue Comment
Comera Life Sciences Holdings Inc achieved in the IV. Quarter 2022 below company average Revenue increase of 9.33% quarter on quarter, to $ 0.25 millions.

IV. Quarter 2022 results seem to be paradoxical, although beneath the ordinary rise of 33.57 %, yet it shows real acceleration compare to the % in the same quarter a year ago.

Within Major Pharmaceutical Preparations industry 78 other companies have achieved higher Revenue quarter on quarter growth. While Comera Life Sciences Holdings Inc 's Revenue growth quarter on quarter, overall rank is 765.


Comera Life Sciences Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Sep 30 2022 period, Comera Life Sciences Holdings Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Comera Life Sciences Holdings Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2022 period, Comera Life Sciences Holdings Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Comera Life Sciences Holdings Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CMRA's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CMRA's Competitors
Revenue Growth for Comera Life Sciences Holdings Inc 's Suppliers
Revenue Growth for CMRA's Customers

You may also want to know
CMRA's Annual Growth Rates CMRA's Profitability Ratios CMRA's Asset Turnover Ratio CMRA's Dividend Growth
CMRA's Roe CMRA's Valuation Ratios CMRA's Financial Strength Ratios CMRA's Dividend Payout Ratio
CMRA's Roa CMRA's Inventory Turnover Ratio CMRA's Growth Rates CMRA's Dividend Comparisons



Companies with similar Revenue increase for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2022
Bausch Health Companies Inc -0.14%$ -0.137 millions
Bio rad Laboratories Inc -0.34%$ -0.339 millions
National Research Corporation-0.40%$ -0.402 millions
Asensus Surgical Inc -0.48%$ -0.485 millions
Teleflex Incorporated-0.51%$ -0.514 millions
Chemed Corporation-0.85%$ -0.851 millions
Fonar Corporation-0.91%$ -0.911 millions
Davita Inc -0.92%$ -0.920 millions
Syneos Health Inc -0.98%$ -0.984 millions
Accuray Incorporated-1.30%$ -1.303 millions
Pliant Therapeutics Inc -1.70%$ -1.701 millions
Royalty Pharma Plc-1.73%$ -1.729 millions
Integra Lifesciences Holdings Corp-1.85%$ -1.850 millions
Novartis Ag-1.98%$ -1.984 millions
Theravance Biopharma inc -1.99%$ -1.987 millions
Orthofix Medical Inc -2.27%$ -2.267 millions
Travere Therapeutics Inc -2.41%$ -2.412 millions
Sangamo Therapeutics Inc -2.70%$ -2.701 millions
Glaukos Corp-2.75%$ -2.748 millions
Community Health Systems Inc -2.85%$ -2.846 millions
West Pharmaceutical Services Inc -3.02%$ -3.024 millions
Petmed Express Inc -3.04%$ -3.042 millions
Novocure Limited-3.59%$ -3.591 millions
Lhc Group Inc -4.33%$ -4.329 millions
Innovage Holding Corp -4.50%$ -4.502 millions
Bristol myers Squibb Company-4.83%$ -4.831 millions
Central Garden and Pet Co-5.10%$ -5.101 millions
Vanda Pharmaceuticals Inc -5.20%$ -5.200 millions
Teva Pharmaceutical Industries Limited-5.27%$ -5.270 millions
Dermtech Inc -5.40%$ -5.403 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IDW's Profile

Stock Price

IDW's Financials

Business Description

Fundamentals

Charts & Quotes

IDW's News

Suppliers

IDW's Competitors

Customers & Markets

Economic Indicators

IDW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071